FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

FSD Pharma Inc. , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announced that on...

Related Keywords

Toronto ,Ontario ,Canada ,Frankfurt ,Brandenburg ,Germany ,Canadian ,Zeeshan Saeed ,Newsfile Corp ,Nasdaq ,Strategic Investments Inc ,Company Classb Subordinate Voting Shares Class ,Pharma Inc ,Nasdaq Stock Market ,Celly Nutrition Corp ,Canadian Securities Exchange ,Company Annual Report On Form ,Company Class ,Securities Exchange ,Frankfurt Stock Exchange ,Lucid Psycheceuticals Inc ,Nasdaq Capital ,Notification Letter ,Classb Subordinate Voting Shares ,Listing Rule ,Nasdaq Capital Market ,Classb Shares ,Nasdaq Listing Rule ,Lucid Psycheceuticals ,Celly Nutrition ,Investments Inc ,Securities Act ,Securities Exchange Act ,Annual Report ,Canadian Securities Administrators ,Executive Co Chairman ,Markets ,